NWBO where not legally required to release topline data in October.
Regulatory guidance doesn't carry the force of law.
Regulators have discretion in deciding how they're enforced.
Moreover if NWBO are already in discussions with regulators then it follows these regulators would not issue statements condemning a firm which has lead to the survival of glioblastoma patients.
Similarly if NWBO was a scam, late, an involved in egregious tomfoolery, then why hasn't the FDA issued a statement against the firm?
Have you contacted the FDA to ask?
Or would you rather conjure up worst case scenarios that have no chance of occurring in this reality?
News 
Market Data 
Discover 
